E-Learning

Why RAPT Therapeutics Stock Gained Over 100% On Monday?

RAPT Therapeutics, Inc. (NASDAQ:RAPT) shares are trading higher after the company disclosed a partnership with Shanghai Jemincare Pharmaceutical. The collaboration is for an exclusive license agreement to develop and commercialize RPT904, a novel anti-IgE monoclonal antibody worldwide, excluding mainland China, Hong Kong, Macau, and Taiwan. RPT904 is designed to provide a potential alternative to omalizumab (Xolair), addressing allergic conditions such as asthma and chronic spontaneous urticaria

Read more

John Miller’s New High-Yield Muni Fund Dominates Market in 2024

(Bloomberg) -- It’s been a banner year for high-yield municipal bonds, and in particular the category’s star money manager, John Miller, who joined First Eagle Investments in January after nearly three decades at Nuveen.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Hav

Read more

Five Key Charts to Watch in Global Commodity Markets This Week

(Bloomberg) -- Volatile weather and the US bird-flu outbreak are making the upcoming holiday menu more expensive as the price of coffee, cocoa and eggs soar. Meanwhile, OPEC expects oil demand to climb in 2025, driven by China, India and other Asian nations. Electricity use also is rising, with a key North American agency revising its projections significantly upward. Also revised higher is demand for coal, contrary to earlier estimates that said its use peaked last year.Most Read from Bloomberg

Read more